Source: CitizenWire

PSG: News: PSG Announces Release of Highly Anticipated 'Trends in Specialty Drug Benefits Report' | CitizenWire

DALLAS, Texas /CitizenWire/ -- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report. Delivering visibility into the complexity of the specialty drug landscape, it offers detailed intelligence through proprietary research. PSG has been researching and reporting on drug benefit design for over [...] The post News: PSG Announces Release of Highly Anticipated 'Trends in Specialty Drug Benefits Report' | CitizenWire appeared on CitizenWire.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Dave Borden's photo - CEO of PSG

CEO

Dave Borden

CEO Approval Rating

90/100

Read more